Teesha D Downton (Teesha Downton)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Myasthenia Gravis

Top Venues

Internal medicine journal

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Abigail R Miller, Aries Balino, Sandy Tun Min, Teesha D Downton, Narayan V Karanth, Alison Backen, Michail Charakidis
Real-world experience of immune checkpoint inhibitors in patients with solid tumours in the Top End of the Northern Territory, Australia from 2016 to 2021: a retrospective observational cohort study. Internal medicine journal (2024)
Teesha D Downton, Fiona Zhou, Davendra Segara, Rinath M Jeselsohn, Elgene Lim
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status. Drug design, development and therapy 16 (2022)
Derrick Ho Wai Siu, Robert Sean O'Neill, Carole A Harris, Justine Wang, Luke Ardolino, Teesha D Downton, Matthew Tong, Jun Hee Hong, Venessa T Chin, Philip R Clingan, Morteza Aghmesheh, Hussein Soudy
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review. Immunotherapy 14 (7) (2022)
Teesha D Downton, Briony J Willcocks, Craig S Boutlis
Acute myopericarditis in a patient recently started on mesalazine for Crohn disease. Internal medicine journal 49 (5) (2020)